ADVFN US – Market Content Editor
-
Reviva Pharmaceuticals shares tumble after $9M public offering priced
Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH) saw its stock dive 39% in premarket trading Friday, following the announcement of a public offering intended to raise roughly $9 million. The company plans to offer 27 million shares of common stock, or equivalents, at $0.335 per share, each paired with one Series E and one Series F warrant,…
-
Dow Jones, S&P, Nasdaq, Wall Street Futures Signal Slight Gains Ahead
U.S. stock futures suggest a modestly higher open on Friday, as investors look to continue the momentum from Thursday’s strong session. Despite September typically being one of the weaker months for equities, major indexes have trended upward over the past few weeks. Optimism surrounding lower interest rates has bolstered the markets, following the Federal Reserve’s…
-
ARS Pharmaceuticals stock rises after Japan approves needle-free epinephrine spray
Shares of ARS Pharmaceuticals Inc. (NASDAQ:SPRY) climbed 7% on Friday following regulatory approval in Japan for the company’s needle-free epinephrine nasal spray, neffy, intended for emergency treatment of severe allergic reactions. Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) authorized neffy in 1 mg and 2 mg doses for adults and children over 15 kilograms, making…
-
Blackstone names Katie Keenan as new Breit CEO after LePatner’s death – WSJ
Blackstone (NYSE:BX) has selected Katie Keenan to lead Breit, one of the firm’s largest funds aimed at individual investors, following the untimely passing of former CEO Wesley LePatner, the Wall Street Journal reported. Keenan, 41, will additionally serve as the global head of Core+ real estate, managing all lower-risk investments across Blackstone’s $325 billion property…
-
Verrica Pharmaceuticals stock jumps on Japan approves YCANTH
Shares of Verrica Pharmaceuticals (NASDAQ:VRCA) jumped 27% on Friday after the biotech said its partner Torii Pharmaceutical secured marketing authorization in Japan for YCANTH (TO-208), a treatment for Molluscum Contagiosum. The green light from Japan’s Ministry of Health, Labour and Welfare also unlocks a $10 million milestone payment to Verrica. The company said it expects…
-
Mexico’s Private Spending Grows in Q2, Annual Comparison Still Negative
Mexico’s private consumption grew 1.2% in the second quarter of 2025 compared with the first three months of the year, data from the national statistics agency showed on Friday. On a year-over-year basis, however, household and business spending slipped 0.4% versus the same quarter in 2024. The report also highlighted that aggregate demand advanced 1.4%…
-
Hess Midstream Shares Slide After Chevron Rig Reduction Outlook
Hess Midstream LP (NYSE:HESM) stock dropped 6.3% on Friday after the company revised its guidance to reflect Chevron’s plan to scale back Bakken rig activity from four to three rigs beginning in the fourth quarter of 2025. The midstream operator now expects 2026 Adjusted EBITDA to remain largely unchanged from 2025, with growth picking up…
-
Daimler Truck and General Dynamics Deepen Collaboration on Military Vehicles
Daimler Truck Holding AG (TG:DTG) and General Dynamics Land Systems Inc. (NYSE:GD) are expanding their cooperation in the defense sector as governments boost military budgets worldwide. The enhanced partnership centers on Daimler’s Mercedes-Benz Special Trucks unit, which produces the Zetros and Unimog all-terrain vehicles currently deployed by NATO members and various armed forces globally. Under…
-
Nvidia targets $500M investment in British autonomous driving startup Wayve
Nvidia (NASDAQ:NVDA), the American chipmaker, has entered a letter of intent to potentially commit $500 million to Wayve, a UK-based self-driving technology company, the startup confirmed Thursday. Wayve, currently active in the United Kingdom and United States, is broadening its testing and development programs into Germany and Japan, expanding its global footprint. The potential investment…
-
Pony AI on track to reach key profitability milestone by early 2026, CFO says
Chinese robotaxi operator Pony AI Inc (NASDAQ:PONY) is expected to hit a significant profit benchmark by the end of 2025 or early 2026, according to the Wall Street Journal, citing statements from CFO Leo Haojun Wang. Wang told the publication that Pony is “well on track” to achieve single-unit economic break-even and could even report…